Novel human BTB/POZ domain-containing zinc finger protein ZBTB1 inhibits transcriptional activities of CRE

PML/RARA Oxidation and Arsenic Binding Initiate the Antileukemia Response of As2O3

(2010) Marion Jeanne et al.   CANCER CELL

Eradication of acute promyelocytic leukemia-initiating cells by PML/RARA-targeting

(2010) Rihab Nasr et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Aberrant Corepressor Interactions Implicated in PML-RARα and PLZF-RARα Leukemogenesis Reflect an Altered Recruitment and Release of Specific NCoR and SMRT Splice Variants

(2010) Brenda J. Mengeling et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

CREB in the Pathophysiology of Cancer: Implications for Targeting Transcription Factors for Cancer Therapy

(2009) K. M. Sakamoto et al.   CLINICAL CANCER RESEARCH

ZIP: a novel transcription repressor, represses EGFR oncogene and suppresses breast carcinogenesis

(2009) Ruifang Li et al.   EMBO JOURNAL

A Novel POK Family Transcription Factor, ZBTB5, Represses Transcription ofp21CIP1Gene

(2009) Dong-In Koh et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Cyclic AMP Response Element-Binding Protein Overexpression: A Feature Associated with Negative Prognosis in Never Smokers with Non-Small Cell Lung Cancer

(2008) H.-S. Seo et al.   CANCER RESEARCH

Growth Suppression of Lung Cancer Cells by Targeting Cyclic AMP Response Element-Binding Protein

(2008) S. Aggarwal et al.   CANCER RESEARCH

Zbtb4 represses transcription of P21CIP1 and controls the cellular response to p53 activation

(2008) Axel Weber et al.   EMBO JOURNAL